Vertex Pharmaceuticals (VRTX) Common Equity (2009 - 2026)
Vertex Pharmaceuticals (VRTX) posted Common Equity of $20.2 billion for Q2 2026, up 4.58% on a QoQ basis from $19.4 billion in Q1 2026, and up 17.89% year-over-year from $17.2 billion in Q2 2025.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Common Equity (2009 - 2026) Analysis & Trends
Vertex Pharmaceuticals has reported Common Equity for 18 years, with the latest figure at $20.2 billion in Q2 2026.
- On a quarterly basis, Common Equity rose 17.89% year-over-year to $20.2 billion in Q2 2026; TTM through Jun 2026 was $20.2 billion, a 17.89% increase from a year earlier, with the FY2025 full-year figure at $18.7 billion, up 13.75% from the prior year.
- Common Equity was $20.2 billion for Q2 2026 at Vertex Pharmaceuticals, up from $19.4 billion in the prior quarter.
- The five-year high for Common Equity was $20.2 billion in Q2 2026, with the low at $10.9 billion in Q1 2022.
- Average Common Equity over 5 years is $16.0 billion, with a median of $16.5 billion recorded in 2024.
- The sharpest annual moves came in 2022 and 2025: Common Equity surged 37.75% in 2022, then decreased 11.05% in 2025.
- Over 5 years, Common Equity stood at $13.9 billion in 2022, then climbed by 26.36% to $17.6 billion in 2023, then fell by 6.66% to $16.4 billion in 2024, then advanced by 13.75% to $18.7 billion in 2025, then climbed by 8.48% to $20.2 billion in 2026.
- The last three Common Equity figures came in at $20.2 billion (Q2 2026), $19.4 billion (Q1 2026), and $18.7 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | 106.07 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Bristol Myers Squibb | 124.95 Bn | 113.89 Bn | 9.25 Bn | 22.32 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.25 Bn |
| Mar 31, 2026 | 19.36 Bn |
| Dec 31, 2025 | 18.67 Bn |
| Sep 30, 2025 | 17.32 Bn |
| Jun 30, 2025 | 17.18 Bn |
| Mar 31, 2025 | 16.50 Bn |
| Dec 31, 2024 | 16.41 Bn |
| Sep 30, 2024 | 15.63 Bn |
| Jun 30, 2024 | 14.77 Bn |
| Mar 31, 2024 | 18.55 Bn |
| Dec 31, 2023 | 17.58 Bn |
| Sep 30, 2023 | 16.51 Bn |
| Jun 30, 2023 | 15.47 Bn |
| Mar 31, 2023 | 14.43 Bn |
| Dec 31, 2022 | 13.91 Bn |
| Sep 30, 2022 | 13.03 Bn |
| Jun 30, 2022 | 11.93 Bn |
| Mar 31, 2022 | 10.91 Bn |
| Dec 31, 2021 | 10.10 Bn |
| Sep 30, 2021 | 9.53 Bn |
API Access
Vertex Pharmaceuticals Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();